What are Thrombophilia biomarkers
Thrombophilia biomarkers are measurable signals that reveal an inherited or acquired tilt toward forming blood clots. They read the balance in your clotting system—the machinery that seals injuries (coagulation) and the built-in brakes that keep blood flowing (anticoagulants). Core markers include the amount or activity of the natural brakes antithrombin, protein C, and protein S (SERPINC1, PROC, PROS1); DNA variants that make clotting harder to turn off, such as Factor V Leiden (F5 R506Q) and the prothrombin G20210A change (F2); and autoimmune flags that trigger clotting on healthy surfaces, the antiphospholipid antibodies (anticardiolipin, anti–β2 glycoprotein I, lupus anticoagulant). Together they show whether your blood’s “stop” signals are weak, its “go” signals are too strong, or the system is being misdirected. Testing turns this biology into practical decisions: explaining unexpected clots, estimating recurrence risk, tailoring the intensity and duration of anticoagulation, and planning protection around life events that raise clot risk (surgery, immobilization, pregnancy, or estrogen use). It can also guide when family members might benefit from evaluation.
Why is blood testing for Thrombophilia important?
- Spot pro-thrombotic and inflammatory signals that can raise blood clot risk.
- Flag vessel lining stress via elevated homocysteine, a modifiable clotting risk factor.
- Identify body-wide inflammation with C-reactive protein (CRP), which can amplify thrombotic tendencies.
- Check platelet counts to clarify clotting risk from count extremes or reactive states.
- Assess immune activation with the neutrophil-to-lymphocyte ratio (NLR), linking inflammation to clot risk.
- Protect fertility and pregnancy by uncovering inflammation or homocysteine-related pregnancy complications.
- Guide targeted care, optimize B vitamins, and track trends for sustained risk reduction.
- Best interpreted alongside symptoms, family history, coagulation tests, D-dimer, and antiphospholipid antibodies.
What insights will I get?
Thrombophilia blood testing provides insight into your body’s tendency to form blood clots, a process that can impact cardiovascular health, energy delivery, brain function, and even reproductive outcomes. At Superpower, we assess four key biomarkers—Homocysteine, C-reactive protein (CRP), Platelets, and the Neutrophil-to-Lymphocyte Ratio (NLR)—to build a systems-level picture of your clotting risk and overall vascular stability.
Homocysteine is an amino acid that, when elevated, can damage blood vessel linings and promote clot formation. CRP is a marker of inflammation; higher levels signal increased inflammatory activity, which can make blood more prone to clotting. Platelets are cell fragments essential for normal clotting, but too many or too few can disrupt the balance between bleeding and clotting. The NLR reflects the balance between two types of white blood cells and serves as a general marker of immune system activation and inflammation, both of which can influence clotting risk.
Together, these biomarkers reveal how well your body maintains the delicate balance between preventing excessive bleeding and avoiding dangerous clots. Stable, healthy levels suggest your vascular and immune systems are working in harmony, supporting efficient circulation and organ function. Imbalances may indicate a higher risk for clot-related complications, affecting everything from heart and brain health to fertility.
Interpretation of these results depends on factors like age, pregnancy, acute illness, medications (such as anticoagulants or hormone therapy), and laboratory methods. These variables can shift biomarker levels, so results are always considered in context.
.avif)
.svg)
.svg)
.svg)
.svg)
.avif)
.svg)
.avif)
.avif)
.avif)
.avif)
.avif)
.svg)
